DISOPYRAMIDE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
When do Disopyramide Phosphate patents expire, and what generic alternatives are available?
Disopyramide Phosphate is a drug marketed by Nesher Pharms, Dr Reddys Labs Sa, Interpharm, Ivax Sub Teva Pharms, Mylan, Rising, Sun Pharm Industries, Superpharm, Teva, and Watson Labs. and is included in eighteen NDAs.
The generic ingredient in DISOPYRAMIDE PHOSPHATE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Disopyramide Phosphate
A generic version of DISOPYRAMIDE PHOSPHATE was approved as disopyramide phosphate by TEVA on February 22nd, 1985.
Summary for DISOPYRAMIDE PHOSPHATE
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 18 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Clinical Trials: | 1 |
Patent Applications: | 1,247 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in DISOPYRAMIDE PHOSPHATE? | DISOPYRAMIDE PHOSPHATE excipients list |
DailyMed Link: | DISOPYRAMIDE PHOSPHATE at DailyMed |
Recent Clinical Trials for DISOPYRAMIDE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Aberdeen | N/A |
University of Oxford | N/A |
Pharmacology for DISOPYRAMIDE PHOSPHATE
Drug Class | Antiarrhythmic |
Medical Subject Heading (MeSH) Categories for DISOPYRAMIDE PHOSPHATE
Anatomical Therapeutic Chemical (ATC) Classes for DISOPYRAMIDE PHOSPHATE
US Patents and Regulatory Information for DISOPYRAMIDE PHOSPHATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nesher Pharms | DISOPYRAMIDE PHOSPHATE | disopyramide phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 071200-001 | Dec 15, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | DISOPYRAMIDE PHOSPHATE | disopyramide phosphate | CAPSULE;ORAL | 070240-001 | Feb 2, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ivax Sub Teva Pharms | DISOPYRAMIDE PHOSPHATE | disopyramide phosphate | CAPSULE;ORAL | 070187-001 | Nov 18, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |